Praveen Tyle's Net Worth

$408 Thousand

Estimate Recalculated Nov 1, 2024 06:29AM EST

Who is Praveen Tyle?

Praveen Tyle does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KIORA PHARMACEUTICALS INC, LEXICON PHARMACEUTICALS, INC., Skye Bioscience, Inc., GI DYNAMICS, INC., and BAUSCH & LOMB INC.

SEC CIK

Praveen Tyle's CIK is 0001296936

Past Insider Trading and Trends

2021 was Praveen Tyle's most active year for acquiring shares with 9 total transactions. Praveen Tyle's most active month to acquire stocks was the month of January. 2021 was Praveen Tyle's most active year for disposing of shares, totalling 5 transactions. Praveen Tyle's most active month to dispose stocks was the month of January. 2004 saw Praveen Tyle paying a total of $2,145,675.00 for 43,000 shares, this is the most they've acquired in one year. In 2007 Praveen Tyle cashed out on 81,492 shares for a total of $208,118.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KIORA PHARMACEUTICALS INC (KPRX) Snapshot price: $3.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+35,714.29%
5K
$3.96
$19,800.00
5.01K
Aug 19
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Feb 1
Form 4
+420.42%
50K
—
—
61.89K
Jul 10
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Jan 25
Form 4
+93.54%
5.75K
—
—
11.89K
Aug 28
Form 4
∞
11.89K
—
—
11.89K
May 1
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
Feb 19
Form 3
—
0
—
—
0
No matching records found

LEXICON PHARMACEUTICALS, INC. (LXRX) Snapshot price: $1.62

EVP, R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+74.19%
51.45K
$7.19
-$119,066.40
120.79K
Feb 28
Form 4
—
0
—
—
0
Feb 11
Form 4
+27.72%
15.05K
$1.96
-$9,494.24
69.34K
Apr 22
Form 4
+262.47%
39.32K
—
—
54.3K
Feb 28
Form 4
—
0
—
—
0
Feb 6
Form 4
+562.20%
12.72K
—
—
14.98K
Feb 28
Form 4
—
0
—
—
0
Feb 7
Form 4
∞
2.26K
$8.53
-$6,209.84
2.26K
Feb 28
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
May 16
Form 3
—
0
—
—
0
No matching records found

Skye Bioscience, Inc. (SKYE) Snapshot price: $5.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 29
Form 4
—
0
—
—
0
Nov 6
Form 4
—
0
—
—
0
Aug 25
Form 4/A
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Sep 14
Form 4
—
0
—
—
0
Jul 22
Form 3
—
0
—
—
0
No matching records found

GI DYNAMICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

BAUSCH & LOMB INC No price found

Senior Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-27.75K
—
—
0
Oct 26
Form 4
—
0
—
—
0
Aug 14
Form 4
-4.11%
-1.17K
$67.46
-$78,793.28
27.27K
Jul 19
Form 4
—
0
—
—
0
May 8
Form 4/A
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Nov 7
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Nov 9
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Feb 16
Form 4
+250.00%
20K
—
—
28K
Jan 31
Form 4
∞
8K
—
—
8K
Jul 19
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found